Therapeutics formulated to target cancer stem cells: Is it in our future?

Por Clayton, Stephanie, Mousa, Shaker A
Publicado em 2011

Current primary open-angle glaucoma treatments and future directions

Por Beidoe, Gabriel, Mousa, Shaker A
Publicado em 2012

The implications of pharmacogenomics in the treatment of HIV-1-infected patients of African descent

Por Clarke, Hector, Mousa, Shaker A
Publicado em 2009

Biosensors: the new wave in cancer diagnosis

Por Bohunicky, Brian, Mousa, Shaker A
Publicado em 2010

Non-small cell lung cancer: current treatment and future advances

Por Zappa, Cecilia, Mousa, Shaker A.
Publicado no Transl Lung Cancer Res (2016)

Angiogenesis modulations in health and disease practical applications of pro-and anti-angiogenesis targets /

Por Mousa, Shaker A., Davis, Paul J.
Publicado em 2013

Prevention strategies for antimicrobial resistance: a systematic review of the literature

Por Caron, Whitney P, Mousa, Shaker A
Publicado em 2010

Bevasiranib for the Treatment of Wet, Age-Related Macular Degeneration

Por Garba, Adinoyi O., Mousa, Shaker A.
Publicado em 2010

Nanotechnology-Based Detection and Targeted Therapy in Cancer: Nano-Bio Paradigms and Applications

Por Mousa, Shaker A., Bharali, Dhruba J.
Publicado em 2011

Preferred drug lists: Potential impact on healthcare economics

Por Ovsag, Kimberly, Hydery, Sabrina, Mousa, Shaker A
Publicado em 2008

Polycystic ovary syndrome and its impact on women’s quality of life: More than just an endocrine disorder

Por Brady, Christine, Mousa, Shaymaa S, Mousa, Shaker A
Publicado em 2009

Omega-3 Fatty Acids EPA and DHA: Health Benefits Throughout Life

Por Swanson, Danielle, Block, Robert, Mousa, Shaker A.
Publicado em 2012

Pharmacogenomics in cardiovascular disorders: Steps in approaching personalized medicine in cardiovascular medicine

Por Barone, Christopher, Mousa, Shaymaa S, Mousa, Shaker A
Publicado em 2009

Pharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine

Por Avery, Peter, Mousa, Shaymaa S, Mousa, Shaker A
Publicado em 2009

Comparative effectiveness of aflibercept for the treatment of patients with neovascular age-related macular degeneration

Por Thomas, Michael, Mousa, Shaymaa S, Mousa, Shaker A
Publicado em 2013

Multifunctional Nanomaterials and Their Applications in Drug Delivery and Cancer Therapy

Por Srinivasan, Mathangi, Rajabi, Mehdi, Mousa, Shaker A.
Publicado no Nanomaterials (Basel) (2015)

Peroxisome Proliferator-Activated Receptor Agonists: Do They Increase Cardiovascular Risk?

Por Aljada, Ahmad, Shah, Kshitij Ashwin, Mousa, Shaker A.
Publicado em 2009

Behavioral Intervention versus Pharmacotherapy or Their Combinations in the Management of Overactive Bladder Dysfunction

Por Tran, Khanh, Levin, Robert M., Mousa, Shaker A.
Publicado em 2009

High Density Lipoprotein (HDL) Modulation Targets

Por Mousa, Shaymaa S., Block, Robert C., Mousa, Shaker A.
Publicado em 2010

Pharmacogenetics in breast cancer: steps toward personalized medicine in breast cancer management

Por Rofaiel, Sarah, Muo, Esther N, Mousa, Shaker A
Publicado em 2010